Devcon Scholars Program Returns for Devcon SEA!
We are excited to announce the return of the Devcon Scholars Program for Devcon Southeast Asia! Bringing together builders from diverse geographies and disciplines, the Devcon Scholars Program offers more than just a scholarship to attend Devcon – it a…
Silkworms help grow better organ-like tissues in labs
Biomedical engineers have developed a silk-based, ultrathin membrane that can be used in organ-on-a-chip models to better mimic the natural environment of cells and tissues within the body. When used in a kidney organ-on-a-chip platform, the membrane h…
Scientists ‘read’ the messages in chemical clues left by coral reef inhabitants
What species live in this coral reef, and are they healthy? Chemical clues emitted by marine organisms might hold that information. But in underwater environments, invisible compounds create a complex ‘soup’ that is hard for scientists to decipher. Now…
Diagnosing damaged infrastructure from space
Synthetic Aperture Radar (SAR) remote sensing systems allow researchers to inspect and characterize pavements, retaining walls, and embankments from space and can help determine if there are flaws that should be further inspected for repair.
Potential treatment for fibrosis
Researchers are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body’s tissues.
Discovery highlights ‘critical oversight’ in perceived security of wireless networks
A research team has uncovered an eavesdropping security vulnerability in high-frequency and high-speed wireless backhaul links, widely employed in critical applications such as 5G wireless cell phone signals and low-latency financial trading on Wall St…
June 7, 2024 — In The Know with Cathie Wood
On episode LVI of “In the Know,” (June 7, 2024) ARK CEO/CIO, Cathie Wood discusses Elon Musk’s pay package, and weighs in on M2 money supply, the 10 year treasury yield, gold value, and more.
Encouraging Phase 1 data for glioblastoma treatment
Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months with concomitant tem…
Climate crisis puts Australia’s ski industry on slippery slope, but not all hope is lost
Australia’s ski industry is at risk of major disruptions and shorter seasons if the current level of climate pollution continues, according to new modelling. The report found the average ski season across all resorts in Australia will be 44 days shorte…
Epstein-Barr Virus and brain cross-reactivity: possible mechanism for Multiple Sclerosis
The role that Epstein-Barr Virus (EBV) plays in the development of Multiple Sclerosis may be caused a higher level of cross-reactivity, where the body’s immune system binds to the wrong target, than previously thought.